Yaacov Michlin - BioLight Life Chief Officer
| BOLT Stock | ILS 505.00 6.00 1.20% |
Insider
Yaacov Michlin is Chief Officer of BioLight Life Sciences
| Age | 54 |
| Phone | 972 7 327 53400 |
| Web | https://bio-light.co.il |
BioLight Life Management Efficiency
The company has return on total asset (ROA) of (0.0925) % which means that it has lost $0.0925 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0911) %, meaning that it generated substantial loss on money invested by shareholders. BioLight Life's management efficiency ratios could be used to measure how well BioLight Life manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jon MD | Opko Health | 68 | |
| Rami Myerson | Elbit Systems | N/A | |
| Iris Avner | Tower Semiconductor | 54 | |
| Elias MD | Opko Health | 72 | |
| Yifat Esq | Kamada | 47 | |
| Kathleen Veit | Teva Pharmaceutical Industries | N/A | |
| Janet Vergis | Teva Pharmaceutical Industries | 54 | |
| Andrew Weil | Teva Pharmaceutical Industries | 52 | |
| Haim Delmar | Elbit Systems | 49 | |
| Yoav Chelouche | Tower Semiconductor | 66 | |
| Noit LevyKaroubi | Tower Semiconductor | 38 | |
| Arie Gutman | Opko Health | 69 | |
| Abbas Hussain | Teva Pharmaceutical Industries | 54 | |
| Ariella Raban | Kamada | 48 | |
| Yaacov Kagan | Elbit Systems | N/A | |
| James DeMarco | Opko Health | N/A | |
| Deborah Griffin | Teva Pharmaceutical Industries | N/A | |
| MBA MBA | Opko Health | 75 | |
| Dani Ashkenazi | Tower Semiconductor | 60 | |
| Ronit SatchiFainaro | Teva Pharmaceutical Industries | 46 | |
| Eran Nir | Kamada | 51 | |
Management Performance
| Return On Equity | -0.0911 | |||
| Return On Asset | -0.0925 |
BioLight Life Sciences Leadership Team
Elected by the shareholders, the BioLight Life's board of directors comprises two types of representatives: BioLight Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioLight. The board's role is to monitor BioLight Life's management team and ensure that shareholders' interests are well served. BioLight Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioLight Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yifftach CPA, Chief Officer | ||
| Ronit Gross, CoFounder | ||
| Karin Gurevitz, Vice President General Counsel, Secretary | ||
| Ron MD, Chief Board | ||
| Yaacov Michlin, Chief Officer |
BioLight Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BioLight Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0911 | |||
| Return On Asset | -0.0925 | |||
| Current Valuation | 13.59 M | |||
| Shares Outstanding | 4.56 M | |||
| Shares Owned By Insiders | 56.36 % | |||
| Shares Owned By Institutions | 9.12 % | |||
| Price To Earning | 82.18 X | |||
| Price To Book | 0.61 X | |||
| Price To Sales | 4,937 X | |||
| Revenue | 3 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in BioLight Stock
BioLight Life financial ratios help investors to determine whether BioLight Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioLight with respect to the benefits of owning BioLight Life security.